InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,591.66
(
-0.75%
)
US TECH 100
19,735.20
(
-1.90%
)
Dow Jones
39,779.95
(
0.15%
)
Brent Oil
84.96
(
-0.11%
)
Bitcoin
57,450.41
(
-0.53%
)
Post# of 105534
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

ttattletell

Send PM Follow Ignore
Followers 0
Posts 4670
Boards Moderated 0
Alias Born 10/01/2007

ttattletell

Re: None

Sunday, 12/19/2010 6:23:57 PM

Sunday, December 19, 2010 6:23:57 PM

Post# of 105534
CBAI had to pony up to Pharmastem, right?

Page 12-
"Pharmastem - In March 2004, Cord entered into a Patent License Agreement with the holder of patents utilized in the collection, processing, and storage of umbilical cord blood to settle litigation against Cord for alleged patent infringements. The Patent License Agreement calls for royalties of 15% of processing and storage revenue, with a minimum royalty of $225 per specimen collected, on all specimens collected after January 1, 2004 until the patents expire in 2010."
http://www.sec.gov/Archives/edgar/data/1289496/000135448810003655/cbai_10q.htm
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up